Scattered and rapid intrahepatic recurrences after radio frequency ablation for hepatocellular carcinoma

Kazuhiro Kotoh, Munechika Enjoji, Eiichirou Arimura, Shusuke Morizono, Motoyuki Kohjima, Hironori Sakai, Makoto Nakamuta

Research output: Contribution to journalArticlepeer-review

43 Citations (Scopus)


Aim: To evaluate a series of patients with hepatocellular carcinoma (HCC) treated with several different protocols and devices. Methods: We treated 138 patients [chronic hepatitis/liver cirrhosis (Child-Pugh A/B/C), 3/135 (107/25/3)] with two different devices and protocols: cool-tip needle [initial ablation at 60 W (standard method) (n = 37) or at 40 W (modified method) (n = 28)] or; ablation with a LeVeen needle using a standard single-step, full expansion (single-step) method (n = 39) or a multi-step, incremental expansion (multi-step) method. Results: Eleven patients experienced rapid and scattered recurrences 1 to 7 mo after the ablation. Nine patients were treated by the cool-tip original protocol (60 W) (9/37 = 24%) and the other two by the LeVeen single-step method (2/39 = 5%). The location of the recurrence was surrounding and limited to the site of ablation segment in three cases, and spread over one lobule or both lobules in the other eight cases. There was no recurrence in the patients treated with the modified cool-tip modified method (40 W) or the LeVeen multi-step method. Conclusion: There is a risk of rapid and scattered recurrence after RFA, especially when the standard cool-tip procedure is used. Because such recurrence would worsen the prognosis, we recommend that modified protocols for the cool-tip and LeVeen needle methods should be used in clinical practice.

Original languageEnglish
Pages (from-to)6828-6832
Number of pages5
JournalWorld Journal of Gastroenterology
Issue number43
Publication statusPublished - Nov 21 2005

All Science Journal Classification (ASJC) codes

  • Gastroenterology


Dive into the research topics of 'Scattered and rapid intrahepatic recurrences after radio frequency ablation for hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this